Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept imatinib for prevention of COVID-19 in aged nursing home residents
2020-001251-41Phase 2Terminated
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of imatinib in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier de Versailles. Primary endpoint: Prevention of SARS-CoV-2 infection. Started Mar 2020; status: terminated.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001251-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001251-41.